INTECH Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.62M Sell
14,380
-2,684
-16% -$1.24M 0.07% 245
2026
Q1
$8.19M Sell
17,064
-1,147
-6% -$587K 0.08% 231
2025
Q4
$10.2M Sell
18,211
-184
-1% -$104K 0.09% 187
2025
Q3
$9.46M Buy
18,395
+4,448
+32% +$1.94M 0.08% 208
2025
Q2
$4.38M Sell
13,947
-7,407
-35% -$2.22M 0.04% 392
2025
Q1
$6.51M Buy
21,354
+8,097
+61% +$2.72M 0.07% 259
2024
Q4
$4.4M Buy
13,257
+7,617
+135% +$2.58M 0.04% 365
2024
Q3
$1.88M Sell
5,640
-2,256
-29% -$857K 0.02% 507
2024
Q2
$3.25M Buy
+7,896
New +$3.13M 0.04% 339

Other funds holding MEDP

INTECH Investment Management's MEDP Position: Q2 2026 in Review

INTECH Investment Management reduced its Medpace (MEDP) stake by 16% in Q2 2026, selling an estimated $1.24M and leaving 14,380 shares worth $7.62M. The position accounts for 0.07% of the portfolio, ranked #245.

INTECH Investment Management first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.2M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • INTECH Investment Management held 14,380 shares of Medpace worth $7.62M as of Q2 2026.
  • INTECH Investment Management sold 2,684 Medpace shares in Q2 2026, an estimated $1.24M.
  • Medpace made up 0.07% of INTECH Investment Management's portfolio in Q2 2026, its #245 holding.
  • INTECH Investment Management first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's Medpace position peaked at $10.2M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.